IMUTEX
Imutex, a startup with a Phase IIa-ready universal flu vaccine.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed IMUTEX Information
Geographic Data
Address: Registered address 100 Fetter Lane
City: Greater London
State: england
Zip: EC4A 1BN
Country: GB
Financial Info
Stage:
seed
Raised Last:
$20M
Raised Total:$20M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Imutex Limited, formed in 2016, is a joint venture between SEEK Group and hVIVO plc to accelerate the development of a Broad-Spectrum Influenza Vaccine (BIV) and a Zika Vaccine. The development of BIV and Zika vaccines are key public health priorities identified by the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) in the United States.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
